CONMED makes and sells surgical devices and equipment, primarily for minimally invasive procedures, serving hospitals, ambulatory surgery centers, and surgeons. The business is split across two segments: Orthopedic Surgery (~42% of revenue) and General Surgery (~58% of revenue). In orthopedics, CONMED sells sports medicine implants and instruments, powered surgical tools under the Hall brand, and foot and ankle systems, with BioBrace — a biologic scaffold implant for soft tissue repair used across 70+ procedures — as the primary growth driver. In general surgery, the flagship product is AirSeal, a proprietary valveless insufflation system used in robotic and laparoscopic surgeries that maintains stable, low-pressure abdominal cavity inflation. CONMED also sells Buffalo Filter, a surgical smoke evacuation system driven by mandatory smoke-free OR legislation now enacted in 20 U.S. states. CONMED's business model follows a razor-and-blade structure: capital equipment (AirSeal consoles, smoke evacuators, powered instruments) is placed with customers, generating ongoing single-use disposable revenue with each procedure. Roughly 90% of general surgery revenue and ~78% of orthopedic revenue is recurring. CONMED sells directly in the U.S. through a commissioned sales force and via distributors internationally, with international sales accounting for ~32% of revenue. CONMED is exiting its gastroenterology product lines in 2026 to concentrate resources on AirSeal, Buffalo Filter, and BioBrace — its three designated high-growth platforms.